Lachlan Brown

Stock Analyst

(n/a)
# 4,648
Out of 4,653 analysts
4
Total ratings
n/a
Success rate
n/a
Average return

Stocks Rated by Lachlan Brown

Apellis Pharmaceuticals
Oct 16, 2024
Initiates: Outperform
Price Target: n/a
Current: $29.26
Upside: -
The Descartes Systems Group
May 14, 2024
Initiates: Neutral
Price Target: $90
Current: $115.17
Upside: -21.85%
Manhattan Associates
May 14, 2024
Initiates: Buy
Price Target: $260
Current: $284.34
Upside: -8.56%
SPS Commerce
May 14, 2024
Initiates: Buy
Price Target: $220
Current: $186.77
Upside: +17.79%